| Literature DB >> 26528169 |
Brendan M Caldwell1, Carla L Harenski1, Keith A Harenski1, Samantha J Fede2, Vaughn R Steele3, Michael R Koenigs4, Kent A Kiehl2.
Abstract
Investigations into the neurobiology of moral cognition are often done by examining clinical populations characterized by diminished moral emotions and a proclivity toward immoral behavior. Psychopathy is the most common disorder studied for this purpose. Although cocaine abuse is highly co-morbid with psychopathy and cocaine-dependent individuals exhibit many of the same abnormalities in socio-affective processing as psychopaths, this population has received relatively little attention in moral psychology. To address this issue, the authors used functional magnetic resonance imaging (fMRI) to record hemodynamic activity in 306 incarcerated male adults, stratified into regular cocaine users (n = 87) and a matched sample of non-cocaine users (n = 87), while viewing pictures that did or did not depict immoral actions and determining whether each depicted scenario occurred indoors or outdoors. Consistent with expectations, cocaine users showed abnormal neural activity in several frontostriatial regions during implicit moral picture processing compared to their non-cocaine using peers. This included reduced moral/non-moral picture discrimination in the vACC, vmPFC, lOFC, and left vSTR. Additionally, psychopathy was negatively correlated with activity in an overlapping region of the ACC and right lateralized vSTR. These results suggest that regular cocaine abuse may be associated with affective deficits which can impact relatively high-level processes like moral cognition.Entities:
Keywords: Cocaine; Moral Intuition; Psychopathy; Social Cognition; fMRI
Year: 2015 PMID: 26528169 PMCID: PMC4608360 DOI: 10.3389/fnhum.2015.00565
Source DB: PubMed Journal: Front Hum Neurosci ISSN: 1662-5161 Impact factor: 3.169
Demographic information of incarcerated cocaine users and non-cocaine users.
| Age | 32.15 | 8.07 | 34.9 | 8.08 | 33.59 | 8.90 |
| IQ | 98.66 | 13.66 | 100.62 | 13.09 | 99.34 | 13.27 |
| PCLR Total | 22.265 | 7.4594 | 24.34 | 6.11 | 23.31 | 7.82 |
| PCLR Factor 1 | 8.037 | 3.7866 | 8.05 | 3.73 | 8.05 | 3.99 |
| PCLR Factor 2 | 12.186 | 4.2716 | 13.86 | 3.13 | 13.04 | 4.29 |
| Alcohol | 0.105 | 0.148 | 0.205 | 0.195 | 0.17 | 0.18 |
| Cannabis | 0.199 | 0.198 | 0.351 | 0.208 | 0.31 | 0.21 |
| Heroin | 0.061 | 0.054 | 0.122 | 0.105 | 0.02 | 0.09 |
| Other Opiates | 0.018 | 0.067 | 0.056 | 0.101 | 0.03 | 0.09 |
| Cocaine | 0.000 | 0.000 | 0.136 | 0.141 | 0.00 | 0.00 |
| Methamphetamine | 0.007 | 0.043 | 0.051 | 0.128 | 0.01 | 0.07 |
| Other Amphetamines | 0.007 | 0.034 | 0.026 | 0.095 | 0.01 | 0.05 |
| Nicotine | 0.248 | 0.223 | 0.408 | 0.194 | 0.36 | 0.23 |
| American Indian/Alaskan Native | 12 | 5.5 | 0 | 0 | 7 | 8 |
| Asian | 1 | 0.5 | 0 | 0 | 1 | 1.1 |
| Black | 73 | 33.3 | 13 | 14.9 | 27 | 31 |
| Native Hawaiian/Pacific Islander | 3 | 1.4 | 0 | 0 | 0 | 0 |
| White | 111 | 50.7 | 59 | 67.8 | 44 | 50.6 |
| Other/Decline | 19 | 8.7 | 15 | 17.2 | 8 | 9.2 |
| Not Hispanic | 193 | 88.1 | 64 | 73.6 | 77 | 88.5 |
| Hispanic | 26 | 11.9 | 23 | 26.4 | 10 | 11.5 |
| Right | 184 | 84 | 78 | 89.7 | 73 | 83.9 |
| Left | 26 | 11.9 | 7 | 8 | 11 | 12.6 |
| Ambidextrous | 9 | 41 | 2 | 2.3 | 3 | 3.4 |
For each substance, substance use history is represented by the proportion of an individual's lifetime the substance was being used regularly (e.g., Alcohol Use = 0.1044 means the participant used alcohol regularly for 10.44% of his life).
Group comparisons of demographic information for incarcerated cocaine users and non-cocaine users.
| Age | 2.69 | 304 | 0.008 | 1.02 | 172 | 0.312 |
| IQ | 1.15 | 304 | 0.252 | 0.64 | 172 | 0.523 |
| PCLR Total | 2.51 | 191.4 | 0.013 | 0.97 | 163 | 0.336 |
| PCLR Factor 1 | 0.02 | 304 | 0.984 | 0.00 | 172 | 1.000 |
| PCLR Factor 2 | 3.74 | 217.33 | 0.000 | 1.42 | 152 | 0.158 |
| Alcohol | 4.34 | 127.44 | 0.000 | 1.16 | 172 | 0.246 |
| Cannabis | 5.98 | 304 | 0.000 | 1.60 | 172 | 0.112 |
| Heroin | 3.02 | 107.90 | 0.003 | 1.45 | 169 | 0.150 |
| Other Opiates | 3.24 | 116.88 | 0.002 | 1.43 | 172 | 0.155 |
| Cocaine | 9.00 | 86 | 0.000 | 9.12 | 172 | 0.000 |
| Methamphetamine | 3.14 | 93.791 | 0.002 | 2.37 | 172 | 0.019 |
| Other Amphetamines | 1.82 | 94.704 | 0.073 | 1.08 | 172 | 0.283 |
| Nicotine | 6.22 | 180.47 | 0.000 | 1.62 | 172 | 0.107 |
| Race | 21.25001 | 5 | 0.001 | 17.2149 | 4 | 0.002 |
| Ethnicity | 9.82098 | 1 | 0.002 | 6.319794 | 1 | 0.012 |
| Handedness | 1.644219 | 2 | 0.440 | 1.25 | 2 | 0.534 |
For each substance, substance use history is represented by the proportion of an individual's lifetime the substance was being used regularly.
Imaging results for healthy controls and full incarcerated sample.
| L. TPJ | 39 | −48 | −60 | 30 | 5.05 | 594 | 0.000 | −51 | −60 | 27 | 13.53 | 7810 | 0.000 |
| R. TPJ | 39 | 54 | −48 | 24 | 4.55 | 213 | 0.004 | 54 | −54 | 24 | 10.14 | ||
| L. Fusiform | 19/37 | −21 | −45 | −9 | 3.65 | 29 | 0.95 | −24 | −42 | −12 | 13.19 | ||
| L. MTG | 21 | −48 | −18 | −18 | 3.49 | 16 | 0.998 | −57 | −21 | −12 | 8.09 | ||
| L. MTG | 21 | −51 | −33 | −3 | 3.1 | 6 | 1 | −60 | −36 | −6 | 7.02 | ||
| B. PCC | 23/31 | 6 | −60 | 30 | 4.8 | 236 | 0.002 | 0 | −18 | 39 | 3.32 | 4 | 0.979 |
| L. dmPFC | 9 | −9 | 60 | 33 | 4.13 | 118 | 0.076 | −3 | 48 | 36 | 9.39 | 3063 | 0.000 |
| L. rostral ACC | 32 | 15 | 39 | 15 | 3.22 | 2 | 1 | −6 | 51 | 15 | 8.84 | ||
| L. dlPFC | 8 | −42 | 15 | 54 | 3.91 | 24 | 0.981 | −48 | 15 | 45 | 8.4 | ||
| R. dlPFC | 8 | 24 | 27 | 54 | 3.35 | 12 | 1 | 45 | 15 | 45 | 5.5 | 149 | 0.001 |
| L. vmPFC | 47 | −33 | 21 | −21 | 3.79 | 22 | 0.988 | −30 | 21 | −15 | 4.95 | ||
| L. vmPFC | 10 | −21 | 60 | 21 | 2.8 | 1 | 1 | −24 | 57 | 27 | 5.08 | ||
| R. vmPFC | 10 | 3 | 57 | −9 | 2.77 | 1 | 1 | −3 | 57 | −9 | 6.42 | ||
| L. vlPFC | 45/44 | −54 | 21 | 18 | 3.62 | 12 | 1 | −57 | 21 | 15 | 5.91 | ||
| R. vlPFC | 47 | 42 | 30 | −12 | 3.72 | 9 | 0.879 | ||||||
| L. ventral ACC | 32 | −12 | 45 | 0 | 3.39 | 8 | 1 | −30 | 60 | 12 | 3.36 | 5 | 0.965 |
| L. Putamen | 49 | −21 | 9 | 9 | 3.3 | 17 | 0.998 | −12 | 3 | 9 | 3.28 | 2 | 0.995 |
| L. Temporal Pole | 38 | −51 | 6 | −33 | 2.98 | 2 | 1 | −39 | 18 | −33 | 3.19 | 1 | 0.998 |
| R. Cerebellum | NA | 18 | −72 | −30 | 2.25 | 10 | 1 | 24 | −81 | −33 | 6.25 | 375 | 0.000 |
| R. Thalamus | 50 | 18 | −15 | 0 | 2.65 | 19 | 1 | 15 | −21 | 9 | 3.89 | 4 | 0.979 |
BA, Brodmann area; t, t score; k, spatial extent of activation; p, corrected p-value. Activations are reported in MNI coordinate space. Areas in which the Incarcerated sample showed greater activation than Healthy Controls are highlighted in red. Areas in which the Healthy Controls showed greater activation than the Incarcerated sample are highlighted in green. TPJ, Temporoparietal Junction; MTG, Middle Temporal Gyrus; PCC, Posterior Cingulate Cortex; dmPFC, Dorsomedial Prefrontal Cortex; ACC, Anterior Cingulate Cortex; dlPFC, Dorsolateral Prefrontal Cortex; vmPFC, Ventromedial Prefrontal Cortex; vlPFC, Ventrolateral Prefrontal Cortex.
Figure 1Main Effect of Moral > Non-Moral condition in healthy controls (p-threshold = 0.05).
Imaging results from group comparison of Cocaine Users (CU) and Matched Non-Cocaine Users (mNCU).
| L. subgenual ACC | 32/25 | −6 | 21 | −3 | 4.62 | 52 | 0.056 |
| R. Superior Frontal Gyrus | 10 | 24 | 48 | 12 | 4.88 | 39 | 0.134 |
| R. Middle Frontal Gyrus* | 10/32 | 21 | 45 | 12 | 4.04 | 64 | 0.004 |
| R. Inferior Frontal Gyrus* | 47 | 33 | 24 | −18 | 3.25 | 33 | 0.044 |
| L. Medial Frontal Gyrus* | 10 | −3 | 54 | −6 | 3.32 | 64 | 0.037 |
| L. ventral ACC* | 10/11/32 | −9 | 42 | −6 | 4.05 | 98 | 0.004 |
| R. Cuneus* | 19/18/17 | 12 | −63 | 6 | 3.66 | 124 | 0.014 |
| R. Precuneus* | 7 | 15 | −75 | 54 | 3.7 | 145 | 0.012 |
| R. Parahippocampal Gyrus* | 19/36/37 | 21 | −45 | −6 | 3.51 | 77 | 0.022 |
| L. Middle Temporal Gyrus* | 21/37 | −48 | −48 | −3 | 3.32 | 86 | 0.037 |
| L. Parahippocampal Gyrus* | 36 | −18 | −42 | 0 | 3.62 | 41 | 0.016 |
| L. Thalamus* | 50 | −9 | −3 | 6 | 3.26 | 81 | 0.043 |
| R. Thalamus* | 50/48 | 12 | −6 | 15 | 3.13 | 15 | 0.059 |
| None | |||||||
BA, Brodmann area; t, t score; k, spatial extent of activation. Activations are reported in MNI coordinate space. Regions marked with an asterisk (.
Imaging results from regression with psychopathy within the cocaine users group.
| None | |||||||
| R. ventral Striatum | 52/48 | 9 | 3 | −9 | 3.82 | 17 | 0.011 |
| R. rostral Anterior Cingulate Cortex | 32 | 15 | 33 | 21 | 3.47 | 18 | 0.031 |
| None | |||||||
BA, Brodmann area; t, t score; k, spatial extent of activation. Activations are reported in MNI coordinate space. Regions marked with an asterisk (.
Imaging results from regression with duration of abstinence from cocaine within the cocaine users group.
| None | |||||||
| R. posterior Cingulate Cortex* | 23 | 18 | −60 | 2 | 3.6 | 102 | 0.026 |
BA, Brodmann area; t, t score; k, spatial extent of activation. Activations are reported in MNI coordinate space. Regions marked with an asterisk (.
Figure 2Activity in the left subgenual ACC during the Moral > Non-Moral condition.